Logo image of AMRC

AMERESCO INC-CL A (AMRC) Stock Fundamental Analysis

NYSE:AMRC - New York Stock Exchange, Inc. - US02361E1082 - Common Stock - Currency: USD

15.87  +0.24 (+1.54%)

After market: 15.87 0 (0%)

Fundamental Rating

4

AMRC gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 52 industry peers in the Construction & Engineering industry. AMRC has a bad profitability rating. Also its financial health evaluation is rather negative. AMRC has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

AMRC had positive earnings in the past year.
AMRC had a positive operating cash flow in the past year.
AMRC had positive earnings in each of the past 5 years.
In the past 5 years AMRC reported 4 times negative operating cash flow.
AMRC Yearly Net Income VS EBIT VS OCF VS FCFAMRC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200M -400M -600M

1.2 Ratios

AMRC has a Return On Assets of 1.30%. This is comparable to the rest of the industry: AMRC outperforms 42.31% of its industry peers.
AMRC has a Return On Equity (5.35%) which is in line with its industry peers.
AMRC's Return On Invested Capital of 2.07% is on the low side compared to the rest of the industry. AMRC is outperformed by 61.54% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for AMRC is significantly below the industry average of 16.61%.
Industry RankSector Rank
ROA 1.3%
ROE 5.35%
ROIC 2.07%
ROA(3y)2.11%
ROA(5y)2.51%
ROE(3y)8%
ROE(5y)8.99%
ROIC(3y)3.15%
ROIC(5y)3.6%
AMRC Yearly ROA, ROE, ROICAMRC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

AMRC's Profit Margin of 2.97% is in line compared to the rest of the industry. AMRC outperforms 57.69% of its industry peers.
AMRC's Profit Margin has declined in the last couple of years.
AMRC has a Operating Margin of 4.84%. This is comparable to the rest of the industry: AMRC outperforms 51.92% of its industry peers.
In the last couple of years the Operating Margin of AMRC has declined.
AMRC has a Gross Margin of 14.31%. This is comparable to the rest of the industry: AMRC outperforms 44.23% of its industry peers.
AMRC's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 4.84%
PM (TTM) 2.97%
GM 14.31%
OM growth 3Y-16.55%
OM growth 5Y-4.81%
PM growth 3Y-17.89%
PM growth 5Y-8.97%
GM growth 3Y-8.6%
GM growth 5Y-5.69%
AMRC Yearly Profit, Operating, Gross MarginsAMRC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), AMRC is destroying value.
The number of shares outstanding for AMRC has been increased compared to 1 year ago.
The number of shares outstanding for AMRC has been increased compared to 5 years ago.
The debt/assets ratio for AMRC has been reduced compared to a year ago.
AMRC Yearly Shares OutstandingAMRC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
AMRC Yearly Total Debt VS Total AssetsAMRC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

AMRC has an Altman-Z score of 1.01. This is a bad value and indicates that AMRC is not financially healthy and even has some risk of bankruptcy.
AMRC has a worse Altman-Z score (1.01) than 73.08% of its industry peers.
AMRC has a Debt/Equity ratio of 1.55. This is a high value indicating a heavy dependency on external financing.
AMRC has a worse Debt to Equity ratio (1.55) than 69.23% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.55
Debt/FCF N/A
Altman-Z 1.01
ROIC/WACC0.22
WACC9.23%
AMRC Yearly LT Debt VS Equity VS FCFAMRC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B

2.3 Liquidity

AMRC has a Current Ratio of 1.57. This is a normal value and indicates that AMRC is financially healthy and should not expect problems in meeting its short term obligations.
AMRC has a better Current ratio (1.57) than 80.77% of its industry peers.
AMRC has a Quick Ratio of 1.56. This is a normal value and indicates that AMRC is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of AMRC (1.56) is better than 84.62% of its industry peers.
Industry RankSector Rank
Current Ratio 1.57
Quick Ratio 1.56
AMRC Yearly Current Assets VS Current LiabilitesAMRC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

6

3. Growth

3.1 Past

AMRC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -10.53%.
AMRC shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 3.47% yearly.
The Revenue has grown by 30.13% in the past year. This is a very strong growth!
The Revenue has been growing by 15.34% on average over the past years. This is quite good.
EPS 1Y (TTM)-10.53%
EPS 3Y-12.06%
EPS 5Y3.47%
EPS Q2Q%0%
Revenue 1Y (TTM)30.13%
Revenue growth 3Y13.34%
Revenue growth 5Y15.34%
Sales Q2Q%18.24%

3.2 Future

The Earnings Per Share is expected to grow by 16.33% on average over the next years. This is quite good.
The Revenue is expected to grow by 8.47% on average over the next years. This is quite good.
EPS Next Y-23.67%
EPS Next 2Y6.95%
EPS Next 3Y18.17%
EPS Next 5Y16.33%
Revenue Next Year7.02%
Revenue Next 2Y8.6%
Revenue Next 3Y9.51%
Revenue Next 5Y8.47%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
AMRC Yearly Revenue VS EstimatesAMRC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B 2.5B
AMRC Yearly EPS VS EstimatesAMRC Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5 2 2.5

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 15.56, which indicates a correct valuation of AMRC.
AMRC's Price/Earnings ratio is rather cheap when compared to the industry. AMRC is cheaper than 92.31% of the companies in the same industry.
AMRC's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.55.
A Price/Forward Earnings ratio of 13.60 indicates a correct valuation of AMRC.
Based on the Price/Forward Earnings ratio, AMRC is valued cheaper than 88.46% of the companies in the same industry.
AMRC's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.40.
Industry RankSector Rank
PE 15.56
Fwd PE 13.6
AMRC Price Earnings VS Forward Price EarningsAMRC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

75.00% of the companies in the same industry are more expensive than AMRC, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 13.51
AMRC Per share dataAMRC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

AMRC's earnings are expected to grow with 18.17% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)4.48
EPS Next 2Y6.95%
EPS Next 3Y18.17%

0

5. Dividend

5.1 Amount

No dividends for AMRC!.
Industry RankSector Rank
Dividend Yield N/A

AMERESCO INC-CL A

NYSE:AMRC (6/11/2025, 8:04:00 PM)

After market: 15.87 0 (0%)

15.87

+0.24 (+1.54%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)05-05 2025-05-05/amc
Earnings (Next)08-04 2025-08-04/amc
Inst Owners97.43%
Inst Owner Change-3.84%
Ins Owners7.23%
Ins Owner Change10.56%
Market Cap834.76M
Analysts74.74
Price Target20.81 (31.13%)
Short Float %9.71%
Short Ratio4.59
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)28.04%
Min EPS beat(2)-8.27%
Max EPS beat(2)64.35%
EPS beat(4)1
Avg EPS beat(4)-10.47%
Min EPS beat(4)-66.19%
Max EPS beat(4)64.35%
EPS beat(8)3
Avg EPS beat(8)-4.78%
EPS beat(12)5
Avg EPS beat(12)-1.18%
EPS beat(16)9
Avg EPS beat(16)4.47%
Revenue beat(2)1
Avg Revenue beat(2)6.22%
Min Revenue beat(2)-0.4%
Max Revenue beat(2)12.84%
Revenue beat(4)3
Avg Revenue beat(4)6.79%
Min Revenue beat(4)-0.4%
Max Revenue beat(4)13.75%
Revenue beat(8)6
Avg Revenue beat(8)5.69%
Revenue beat(12)9
Avg Revenue beat(12)4.87%
Revenue beat(16)11
Avg Revenue beat(16)3.9%
PT rev (1m)-0.97%
PT rev (3m)-34.82%
EPS NQ rev (1m)-56.82%
EPS NQ rev (3m)-94.13%
EPS NY rev (1m)0%
EPS NY rev (3m)-55.77%
Revenue NQ rev (1m)-3.59%
Revenue NQ rev (3m)-13.81%
Revenue NY rev (1m)0.05%
Revenue NY rev (3m)-0.72%
Valuation
Industry RankSector Rank
PE 15.56
Fwd PE 13.6
P/S 0.46
P/FCF N/A
P/OCF 12.19
P/B 0.82
P/tB 0.89
EV/EBITDA 13.51
EPS(TTM)1.02
EY6.43%
EPS(NY)1.17
Fwd EY7.35%
FCF(TTM)-7.16
FCFYN/A
OCF(TTM)1.3
OCFY8.2%
SpS34.68
BVpS19.24
TBVpS17.76
PEG (NY)N/A
PEG (5Y)4.48
Profitability
Industry RankSector Rank
ROA 1.3%
ROE 5.35%
ROCE 2.62%
ROIC 2.07%
ROICexc 2.11%
ROICexgc 2.17%
OM 4.84%
PM (TTM) 2.97%
GM 14.31%
FCFM N/A
ROA(3y)2.11%
ROA(5y)2.51%
ROE(3y)8%
ROE(5y)8.99%
ROIC(3y)3.15%
ROIC(5y)3.6%
ROICexc(3y)3.29%
ROICexc(5y)3.76%
ROICexgc(3y)3.41%
ROICexgc(5y)3.91%
ROCE(3y)3.99%
ROCE(5y)4.56%
ROICexcg growth 3Y-23.67%
ROICexcg growth 5Y-13.36%
ROICexc growth 3Y-23.08%
ROICexc growth 5Y-12.71%
OM growth 3Y-16.55%
OM growth 5Y-4.81%
PM growth 3Y-17.89%
PM growth 5Y-8.97%
GM growth 3Y-8.6%
GM growth 5Y-5.69%
F-Score6
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 1.55
Debt/FCF N/A
Debt/EBITDA 8.58
Cap/Depr 471.74%
Cap/Sales 24.39%
Interest Coverage 0.84
Cash Conversion 37.49%
Profit Quality N/A
Current Ratio 1.57
Quick Ratio 1.56
Altman-Z 1.01
F-Score6
WACC9.23%
ROIC/WACC0.22
Cap/Depr(3y)645.79%
Cap/Depr(5y)553.31%
Cap/Sales(3y)27.71%
Cap/Sales(5y)23.19%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-10.53%
EPS 3Y-12.06%
EPS 5Y3.47%
EPS Q2Q%0%
EPS Next Y-23.67%
EPS Next 2Y6.95%
EPS Next 3Y18.17%
EPS Next 5Y16.33%
Revenue 1Y (TTM)30.13%
Revenue growth 3Y13.34%
Revenue growth 5Y15.34%
Sales Q2Q%18.24%
Revenue Next Year7.02%
Revenue Next 2Y8.6%
Revenue Next 3Y9.51%
Revenue Next 5Y8.47%
EBIT growth 1Y6.36%
EBIT growth 3Y-5.42%
EBIT growth 5Y9.79%
EBIT Next Year90.63%
EBIT Next 3Y37.6%
EBIT Next 5Y27.24%
FCF growth 1Y-2.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y2114.03%
OCF growth 3YN/A
OCF growth 5YN/A